Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001567619-21-011735
Filing Date
2021-06-07
Accepted
2021-06-04 19:48:05
Documents
1
Effectiveness Date
2021-06-07
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 10054
  Complete submission text file 0001567619-21-011735.txt   11122
Mailing Address 200 POWDER MILL ROAD BLDG E500 WILMINGTON DE 19803
Business Address 200 POWDER MILL ROAD BLDG E500 WILMINGTON DE 19803 302-644-5446
NiKang Therapeutics, Inc. (Filer) CIK: 0001864608 (see all company filings)

EIN.: 822593817 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-401881 | Film No.: 21997914